Intra-tumour mature tertiary lymphoid structures (TLSs) predict better prognosis and response to immunotherapy in clear cell renal cell cancer

被引：0
|
作者：
Lu, Jiahe [1 ,2 ,3 ]
Xu, Wenhao [1 ,2 ,3 ]
Tian, Xi [1 ,2 ,3 ]
Anwaier, Aihetaimujiang [1 ,2 ,3 ]
Ye, Shiqi [1 ,2 ,3 ]
Wu, Yuhao [4 ]
Liu, Wangrui [5 ]
Zhang, Hailiang [1 ,2 ,3 ]
Ye, Dingwei [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Dept Urol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Genitourinary Canc Inst, Shanghai, Peoples R China
[4] Tongji Univ, Shanghai Skin Dis Hosp, Inst Photomed, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Renji Hosp, Dept Intervent Oncol, Shanghai, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1727 - P2.
引用
收藏
页码：1103 / 1103
页数：1
相关论文
共 50 条
  • [1] Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
    Shang, Taiyu
    Jiang, Tianyi
    Lu, Tao
    Wang, Hui
    Cui, Xiaowen
    Pan, Yufei
    Xu, Mengyou
    Pei, Mengmiao
    Ding, Zhiwen
    Feng, Xiaofan
    Lin, Yunkai
    Li, Xin
    Tan, Yexiong
    Feng, Feiling
    Dong, Hui
    Wang, Hongyang
    Dong, Liwei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Dendritic cell contribution to the development of tertiary lymphoid structures (TLSs) in cancer
    Merad, Miriam
    Mattiuz, Raphael
    Le Berichel, Jessica
    Vaidya, Abishek
    Donne, Romain
    Hamon, Pauline
    Nemeth, Erika
    Troncoso, Leanna
    Reid, Amanda
    Goldstein, Simon
    Belabed, Meriem
    Merand, Raphael
    Hegde, Samarth
    Hennequin, Clotilde
    Park, Matthew D.
    Ozbey, Sinem
    Gnjatic, Sacha
    Lujambio, Amaia
    Schotsaert, Michael
    Joshi, Nikhil S.
    Marron, Thomas U.
    Kamphorst, Alice O.
    CANCER SCIENCE, 2024, 115 : 88 - 88
  • [3] Heterogeneity in tertiary lymphoid structures predicts the distinct prognosis and immune microenvironment of clear cell renal cell carcinoma
    Xu, W.
    Zhang, H.
    Ye, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S1026 - S1026
  • [4] Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
    Xu, Wenhao
    Lu, Jiahe
    Liu, Wang-Rui
    Anwaier, Aihetaimujiang
    Wu, Yuhao
    Tian, Xi
    Su, Jia-Qi
    Qu, Yuan-Yuan
    Yang, Jianfeng
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (12)
  • [5] Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
    Xu, W.
    Zhang, H.
    Ye, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S1561 - S1561
  • [6] Single cell analysis reveals intra-tumour heterogeneity, microenvironment and potential diagnosis markers for clear cell renal cell carcinoma
    Zhang, Man
    Zhai, Wei
    Miao, Juju
    Cheng, Xiaomu
    Luo, Wenqin
    Song, Weichen
    Wang, Jia
    Gao, Wei-Qiang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (05):
  • [7] Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
    Xu, Wenhao
    Lu, Jiahe
    Tian, Xi
    Ye, Shiqi
    Wei, Shiyin
    Wang, Jun
    Anwaier, Aihetaimujiang
    Qu, Yuanyuan
    Liu, Wangrui
    Chang, Kun
    Zhang, Hailiang
    Ye, Dingwei
    MEDCOMM, 2024, 5 (01):
  • [8] Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
    Smith, Christof C.
    Beckermann, Kathryn E.
    Bortone, Dante S.
    De Cubas, Aguirre A.
    Bixby, Lisa M.
    Lee, Samuel J.
    Panda, Anshuman
    Ganesan, Shridar
    Bhanot, Gyan
    Wallen, Eric M.
    Milowsky, Matthew I.
    Kim, William Y.
    Rathmell, W. Kimryn
    Swanstrom, Ronald
    Parker, Joel S.
    Serody, Jonathan S.
    Selitsky, Sara R.
    Vincent, Benjamin G.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11): : 4804 - 4820
  • [9] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
    Viktoria Stühler
    Jens Bedke
    BMC Medicine, 14
  • [10] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors - assessment of intra-tumour heterogeneity
    Stuehler, Viktoria
    Bedke, Jens
    BMC MEDICINE, 2016, 14
12345